Navigation Links
AACR news: Little molecule makes big difference in bladder cancer metastasis
Date:4/9/2013

In order to kill, bladder cancer must metastasize, most commonly to the lung what are the differences between bladder cancers that do and do not make this deadly transition? Research presented by the Director of the University of Colorado Cancer Center at the AACR Annual Meeting 2013 shows that one big difference is a little molecule known as hsa-miR-146a.

Messenger RNA or mRNA carries gene blueprints to sites where the plans are read and made into proteins, and to a large degree microRNA or miRNA tells mRNA what to do. Theodorescu's work shows that in 256 samples of human bladder cancer, especially the tiny miRNA, hsa-miR-146a is overexpressed in the most metastatic tumors. The molecule tells its mRNA partner to manufacture genes in a way that makes bladder cancer metastatic.

"Not only did we discover one specific molecule involved in bladder cancer metastasis, but we discovered a host of miRNA and mRNA pairs that bear further study," says Dan Theodorescu, MD, PhD, director of the CU Cancer Center and the paper's senior author.

Consider this: researchers used to data-mine tumor genomes for mutated genes that could cause cancer. Then researchers discovered that even healthy genes turned on and off or over/under-expressed at unfortunate times could cause cancer and so started looking for mRNA causes of this mis-expression. And now researchers including Theodorescu and colleagues are exploring a layer deeper to discover how miRNA affects mRNA, which affects gene expression, which causes cancer.

"You dig deep enough into these causal chains and you start to learn basic things about this disease and its progression," Theodorescu says.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
805-559-2023
University of Colorado Denver
Source:Eurekalert

Page: 1

Related biology news :

1. AACR news: Six2 homeoprotein allows breast cancer cells to detach and metastasize
2. AACR news: Paragazole excels in preclinical models of triple-negative breast cancer
3. REACH news: European ombudsman takes up PETA complaint
4. Good news: Fewer maternal and child deaths
5. Cell therapy a little more concrete thanks to VIB research
6. Little did we know about beetle diversity: Astonishing 138 new species in a single genus
7. NTU researchers study little mighty creature for scientific breakthrough
8. Chemical fingerprinting tracks the travels of little brown bats
9. Variations of a single gene can lead to too much or too little growth, study shows
10. Enzymes allow DNA to swap information with exotic molecules
11. How the bodys energy molecule transmits 3 types of taste to the brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... February 22, 2017 , ... ... of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, ... , Perkins joins Pennside after more than a decade with leading market research ...
(Date:2/22/2017)... SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., ... UTHR ) today announced its financial results ... 2016. "Our annual 2016 financial results ... billion and earnings exceeded $700 million," said Martine ... Officer. "These financial results strengthen our ability to ...
(Date:2/21/2017)... Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today reported ... December 31, 2016. SQI is a ... develops and commercializes proprietary technologies and products for advanced multiplexed ... ... in fiscal 2016," said Andrew Morris , SQI,s President ...
(Date:2/21/2017)... ... February 21, 2017 , ... Vortex ... , a fully automated benchtop system for collecting intact circulating tumor cells (CTCs) ... at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San ...
Breaking Biology Technology: